Thirty-day hospital revisits after prostate brachytherapy: who is at risk?

Siegel, 2016, Cancer statistics, 2016, CA Cancer J Clin, 66, 7, 10.3322/caac.21332 D'Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969 Ragde, 1998, Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma, Cancer, 83, 989, 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q Korb, 2001, Modern brachytherapy for localized prostate cancers: the northwest hospital (seattle) experience, Rev Urol, 3, 51 Chen, 2006, Patient and treatment factors associated with complications after prostate brachytherapy, J Clin Oncol, 24, 5298, 10.1200/JCO.2006.07.9954 Talcott, 2001, Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated, J Urol, 166, 494 Storey, 1999, Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity, Int J Radiat Oncol Biol Phys, 43, 565, 10.1016/S0360-3016(98)00451-9 Flannigan, 2014, Management of post-radiation therapy complications among prostate cancer patients: a case series, Can Urol Assoc J, 8, E632, 10.5489/cuaj.492 Stone, 2002, Complications following permanent prostate brachytherapy, Eur Urol, 41, 427, 10.1016/S0302-2838(02)00019-2 Healthcare Cost and Utilization Project (HCUP), 2014 User Guide. HCUP Supplemental Variables for Revisit Analyses. Healthcare cost and utilization project (HCUP), https://www.hcup-us.ahrq.gov/toolssoftware/revisit/UserGuide_SuppRevisitFilesCD.pdf. Updated 14 February 2018. Hall, 2003, Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey, Urology, 61, 402, 10.1016/S0090-4295(02)02162-3 Dasenbrock, 2017, Reoperation and readmission after clipping of an unruptured intracranial aneurysm: a national surgical quality improvement program analysis, J Neurosurg, 1 Krumholz, 2013, Post-hospital syndrome–an acquired, transient condition of generalized risk, N Engl J Med, 368, 100, 10.1056/NEJMp1212324 Brownlee, 2017, Impact of post-hospital syndrome on outcomes following elective, ambulatory surgery, Ann Surg, 266, 274, 10.1097/SLA.0000000000001965 van Walraven, 2010, Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community, CMAJ, 182, 551, 10.1503/cmaj.091117 Hollingsworth, 2012, Surgical quality among medicare beneficiaries undergoing outpatient urological surgery, J Urol, 188, 1274 Coley, 2002, Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs, J Clin Anesth, 14, 349, 10.1016/S0952-8180(02)00371-9 Fox, 2014, Hospital-based, acute care after ambulatory surgery center discharge, Surgery, 155, 743, 10.1016/j.surg.2013.12.008 Alibhai, 2005, 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity, J Natl Cancer Inst, 97, 1525, 10.1093/jnci/dji313 Brooke, 2015, Readmission destination and risk of mortality after major surgery: an observational cohort study, Lancet, 386, 884, 10.1016/S0140-6736(15)60087-3 Medicare program, 2016, Hospital outpatient prospective payment and ambulatory surgical center payment systems and quality reporting programs; final rule with comment period and interim final rule with comment period, Fed Regist, 81, 79562 Benoit, 2000, Complications after prostate brachytherapy in the medicare population, Urology, 55, 91, 10.1016/S0090-4295(99)00122-3 Anderson, 2009, Urinary side effects and complications after permanent prostate brachytherapy: the MD anderson cancer center experience, Urology, 74, 601, 10.1016/j.urology.2009.04.060 Nam, 2014, Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study, Lancet Oncol, 15, 223, 10.1016/S1470-2045(13)70606-5 Tsumura, 2011, Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial, Int J Radiat Oncol Biol Phys, 81, e385, 10.1016/j.ijrobp.2011.04.026 Yu, 2016, Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer, World J Urol, 34, 1269, 10.1007/s00345-016-1777-7 Terk, 1998, Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate, J Urol, 160, 1379 Desai, 1998, Acute urinary morbidity following I-125 interstitial implantation of the prostate gland, Radiat Oncol Investig, 6, 135, 10.1002/(SICI)1520-6823(1998)6:3<135::AID-ROI4>3.0.CO;2-Z Mabjeesh, 2007, Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy, Urology, 70, 548, 10.1016/j.urology.2007.04.042